Ensign Peak Advisors, Inc Vaxcyte, Inc. Transaction History

Ensign Peak Advisors, Inc

$55.3 Billion
Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 586,128 shares of PCVX stock, worth $44.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

586,128

Previous 546,835 7.19%

Holding current value

$44.1 Million

Previous $62.4 Million 23.15%

% of portfolio

0.09%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$80.97 - $117.93 $3.18 Million - $4.63 Million	39,293 Added 7.19%	586,128 $48 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $5.93 Million - $9.86 Million	84,153 Added 18.19%	546,835 $62.4 Million
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $781,861 - $1.03 Million	-13,018 Reduced 2.74%	462,682 $34.9 Million
Q1 2024 May 14, 2024	BUY	$59.79 - $81.05 $6.85 Million - $9.29 Million	114,569 Added 31.73%	475,700 $32.5 Million
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $3.87 Million - $5.41 Million	85,345 Added 30.95%	361,131 $22.7 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $932,353 - $1.45 Million	26,900 Added 10.81%	275,786 $13.8 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $12,694 - $16,520	350 Added 0.14%	248,886 $9.33 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $2.98 Million - $6.95 Million	144,961 Added 139.96%	248,536 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $621,743 - $817,812	28,665 Added 38.27%	103,575 $2.49 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $689,696 - $1.04 Million	39,010 Added 108.66%	74,910 $1.63 Million
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $602,020 - $908,892	34,480 Added 2428.17%	35,900 $867,000
Q4 2021 Feb 11, 2022	BUY	$19.32 - $26.45 $27,434 - $37,559	1,420 New	1,420 $34,000
Q2 2021 Aug 13, 2021	SELL	$16.45 - $24.06 $343,360 - $502,204	-20,873 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$26.57 - $51.74 $554,595 - $1.08 Million	20,873 New	20,873 $555,000

Others Institutions Holding PCVX

# of Institutions

350

Shares Held

130M

Call Options Held

539K

Put Options Held

253K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.46B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Vaxcyte, Inc. Transaction History